Skip to main content
Institute for Global Health & Infectious Diseases

2011

 

  1. Braun M, Kabue MM, McCollum ED, et al. Inadequate Coordination of Maternal and Infant HIV Services Detrimentally Affects Early Infant Diagnosis Outcomes in Lilongwe, Malawi. J Acquir Immune Defic Syndr. Jan 10 2011.
  2. Weigel R, Hochgesang M, Brinkhof MW, et al. Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi. BMC Infect Dis. Jan 27 2011;11(1):31.
  3. Powers KA, Hoffman IF, Ghani AC, et al. Sexual Partnership Patterns in Malawi: Implications for HIV/STI Transmission. Sex Transm Dis. Feb 4 2011.
  4. McCollum ED, Preidis GA, Golitko CL, et al. Routine Inpatient Human Immunodeficiency Virus Testing System Increases Access to Pediatric Human Immunodeficiency Virus Care in Sub-Saharan Africa. Pediatr Infect Dis J. Feb 3 2011.
  5. Safren SA, Hendriksen ES, Smeaton L, et al. Quality of Life Among Individuals with HIV Starting Antiretroviral Therapy in Diverse Resource-Limited Areas of the World. AIDS Behav. Apr 16 2011.
  6. Gilles KP, Zimba C, Mofolo I, et al. Factors influencing utilization of postpartum CD4 count testing by HIV-positive women not yet eligible for antiretroviral treatment. AIDS Care. Mar 2011;23(3):322-329.
  7. Akinkuotu A, Roemer E, Richardson A, et al. In-hospital mortality rates and HIV: a medical ward review, Lilongwe, Malawi. Int J STD AIDS. Aug 2011;22(8):465-470.
  8. Robertson K, Kumwenda J, Supparatpinyo K, et al. A multinational study of neurological performance in antiretroviral therapy-naive HIV-1-infected persons in diverse resource-constrained settings. J Neurovirol. Jul 23 2011.
  9. Stuart GS, Moses A, Corbett A, et al. Combined Oral Contraceptives and Antiretroviral PK/PD in Malawian Women: Pharmacokinetics and Pharmacodynamics of a Combined Oral Contraceptive and a Generic Combined Formulation Antiretroviral in Malawi. J Acquir Immune Defic Syndr. Oct 1 2011;58(2):e40-43.
  10. Havlir DV, Kendall MA, Ive P, et al. Timing of Antiretroviral Therapy for HIV-1 Infection and Tuberculosis. N Engl J Med. Oct 20 2011;365(16):1482-1491.
  11. Vorkas CK, Tweya H, Mzinganjira D, et al. Practices to improve identification of adult antiretroviral therapy failure at the Lighthouse Trust clinic in Lilongwe, Malawi. Trop Med Int Health. Nov 1 2011.
  12. Porter KA, Cole SR, Eron JJ, Jr., et al. HIV-1 protease inhibitors and clinical malaria: A secondary analysis of ACTG A5208. Antimicrob Agents Chemother. Nov 28 2011.
  13. Brown KC, Hosseinipour MC, Hoskins JM, et al. Exploration of CYP450 and drug transporter genotypes and correlations with nevirapine exposure in Malawians. Pharmacogenomics. Nov 23 2011.
  14. Chavula C, Long D, Mzembe E, et al. Stopping the control arm in response to the DSMB: Mother’s choice of HIV prophylaxis during breastfeeding in the BAN Study. Contemp Clin Trials. Oct 25 2011.
  15. Eshleman SH, Hudelson SE, Redd AD, et al. Analysis of Genetic Linkage of HIV From Couples Enrolled in the HIV Prevention Trials Network 052 Trial. J Infect Dis. Dec 2011;204(12):1918-1926.
  16. Powers KA, Ghani AC, Miller WC, et al. The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study. Lancet. Jun 17 2011.
  17. Abdool Karim SS, Richardson BA, Ramjee G, et al. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS. Apr 24 2011;25(7):957-966.
  18. Pettifor A, Macphail C, Corneli A, et al. Continued High Risk Sexual Behavior Following Diagnosis with Acute HIV Infection in South Africa and Malawi: Implications for Prevention. AIDS Behav. Aug 2011;15(6):1243-1250.
  19. Woodsong C, Alleman P, Musara P, et al. Preventive Misconception as a Motivation for Participation and Adherence in Microbicide Trials: Evidence from Female Participants and Male Partners in Malawi and Zimbabwe. AIDS Behav. Aug 24 2011.
  20. Akinkuotu A, Samuel JC, Msiska N, Mvula C, Charles AG. The role of the anatomy of the sigmoid colon in developing sigmoid volvulus: a case-control study. Clin Anat. Jul 2011;24(5):634-637.
  21. Samuel JC, Qureshi JS, Mulima G, Shores CG, Cairns BA, Charles AG. An Observational Study of the Etiology, clinical presentation and outcomes associated with peritonitis in Lilongwe, Malawi. World J Emerg Surg. 2011;6(1):37.
  22. Samuel JC, Campbell EL, Mjuweni S, Muyco AP, Cairns BA, Charles AG. The epidemiology, management, outcomes and areas for improvement of burn care in central Malawi: an observational study. J Int Med Res. 2011;39(3):873-879.
  23. Qureshi JS, Samuel J, Lee C, Cairns B, Shores C, Charles AG. Surgery and global public health: the UNC-Malawi surgical initiative as a model for sustainable collaboration. World J Surg. Jan 2011;35(1):17-21.
  24. Parker ME, Bentley ME, Chasela C, et al. The acceptance and feasibility of replacement feeding at 6 months as an HIV prevention method in Lilongwe, Malawi: results from the BAN study. AIDS Educ Prev. Jun 2011;23(3):281-295.
  25. Boltz VF, Zheng Y, Lockman S, et al. Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine. Proc Natl Acad Sci U S A. May 31 2011;108(22):9202-9207.
  26. Petrovski S, Fellay J, Shianna KV, et al. Common human genetic variants and HIV-1 susceptibility: a genome-wide survey in a homogeneous African population. AIDS. Feb 20 2011;25(4):513-518.
  27. Tomaras GD, Binley JM, Gray ES, et al. Polyclonal B Cell Responses to Conserved Neutralization Epitopes in a Subset of HIV-1-infected Individuals. J Virol. Aug 17 2011.
  28. Weiss HA, Paz Bailey G, Phiri S, et al. Episodic therapy for genital herpes in sub-saharan Africa: a pooled analysis from three randomized controlled trials. PLoS ONE. 2011;6(7):e22601.
  29. Brown LB, Miller WC, Kamanga G, et al. HIV partner notification is effective and feasible in sub-Saharan Africa: opportunities for HIV treatment and prevention. J Acquir Immune Defic Syndr. Apr 15 2011;56(5):437-442.